home | contact us
       

   Who are we?
   Mission Statement
   Services
 Case Study
   Vacancies 
 

Centralised Procedure

  • Abridged applications for human medicinal products in the EU are applications made under Article 10(1) of Directive 2001/83/EC, as amended.
  • Abridged applications for veterinary medicinal products in the EU are applications made under Article 13(1) of Directive 2001/82/EC, as amended.
  • The Centralised Procedure (CP) is available to use for generic applications The CP gives the Marketing Authorisation Holder (MAH) a Community Authorisation which allows the MAH to market in all MSs of the EU and EEA on one licence/MA.
  • The CP is fully electronic and Ivowen Limited has full eCTD capability.
  • Ivowen Limited has a wealth of experience in preparing and submitting dossiers using the CP system, for both human and veterinary medicinal products.
  • Ivowen Limited can manage all htmlects of the procedure independently or in liaison with your own Regulatory Affairs department.

Contact us for more information.

   
 
eCTD | Abridged Applications | National Procedures | Mutual Recognition | Decentralised Procedure | Variations | Renewals | Paediatric Investigation Plans (PIPs) and Paediatric Use Marketing Authorisations(PUMAs) | Certificates of suitability | Biostudy Management | Regulatory Strategy | Pharmacovigilance | Compliance | Herbal Medicines | Training | Veterinary Medicinal Products | Project Management